Author

Hui-Ming Chen

Houston Methodist Research institute - Cited by 1,010 - Tumor immunology

Biography

Dr.  Hui-Ming Chen is currently working in Department of Intensive Care Unit, Xiamen Third Hospital, Xiamen, Fujian, China. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work. 
Title
Cited by
Year
DC-SIGN+ macrophages control the induction of transplantation tolerance
P Conde, M Rodriguez, W van der Touw, A Jimenez, M Burns, J Miller, ...Immunity 42 (6), 1143-1158, 2015201
163
2015
Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine
HM Chen, PH Wang, SS Chen, CC Wen, YH Chen, WC Yang, NS YangCancer Immunology, Immunotherapy 61, 1989-2002, 2012201
133
2012
Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity
HM Chen, W van der Touw, YS Wang, K Kang, S Mai, J Zhang, ...The Journal of clinical investigation 128 (12), 5647-5662, 2018201
129
2018
LILRB receptor-mediated regulation of myeloid cell maturation and function
W van der Touw, HM Chen, PY Pan, SH ChenCancer Immunology, Immunotherapy 66, 1079-1087, 2017201
95
2017
Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy
HM Chen, G Ma, N Gildener-Leapman, S Eisenstein, BA Coakley, J Ozao, ...Clinical Cancer Research 21 (18), 4073-4085, 2015201
90
2015
Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy
S Eisenstein, BA Coakley, K Briley-Saebo, G Ma, H Chen, M Meseck, ...Cancer research 73 (16), 5003-5015, 2013201
67
2013
Developing phytocompounds from medicinal plants as immunomodulators
CC Wen, HM Chen, NS YangAdvances in botanical research 62, 197-272, 2012201
45
2012
Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines
CC Wen, HM Chen, SS Chen, LT Huang, WT Chang, WC Wei, LC Chou, ...Journal of biomedical science 18 (1), 1-15, 2011201
43
2011
Natural cures for type 1 diabetes: a review of phytochemicals, biological actions, and clinical potential
CLT Chang, YC Chen, HM Chen, NS Yang, WC YangCurrent Medicinal Chemistry 20 (7), 899-907, 2013201
41
2013
The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells
J Zhang, HM Chen, G Ma, Z Zhou, D Raulet, AL Rivera, SH Chen, PY PanLeukemia 33 (8), 2078-2089, 2019201
38
2019
Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies
J Zhang, S Mai, HM Chen, K Kang, XC Li, SH Chen, PY PanJournal of leukocyte biology 102 (2), 351-360, 2017201
34
2017
Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway
TF Kuo, TY Chen, ST Jiang, KW Chen, YM Chiang, YJ Hsu, YJ Liu, ...Oncogene 36 (39), 5484-5496, 2017201
31
2017
Specific Dioscorea phytoextracts enhance potency of TCL-loaded DC-based cancer vaccines
WT Chang, HM Chen, SY Yin, YH Chen, CC Wen, WC Wei, P Lai, ...Evidence-Based Complementary and Alternative Medicine 2013, 2013201
27
2013
Shikonin enhances efficacy of a gene-based cancer vaccine via induction of RANTES
HM Chen, PH Wang, K Aravindaram, YH Chen, HH Yu, WC Yang, ...Journal of Biomedical Science 19, 1-12, 2012201
27
2012
Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma
K Aravindaram, HH Yu, CW Lan, PH Wang, YH Chen, HM Chen, H Yagita, ...Gene therapy 16 (11), 1329-1339, 2009200
23
2009